Page 18 - Patrick Wingrove News Today : Breaking News, Live Updates & Top Stories | Vimarsana

By Patrick Wingrove (Reuters) - Belgium's drug regulator said it had seized counterfeit versions of semaglutide, the active ingredient in Novo Nordisk...

Eli Lilly on Thursday said it sued 11 online pharmacies to stop them from importing, selling and distributing products claiming to contain the active ingredient in its diabetes drug Mounjaro, which is expected to be approved for weight loss later this year. The Indianapolis-based drugmaker said the suit will go to the U.S. International Trade Commission (ITC). It names the U.S.-based Artic Peptides, Strate Labs, Supopeptide, The Triggered Brand, and Unewlife as defendants, along with Britain’s B

Extraordinary demand for Novo Nordisk’s Ozempic and other drugs used for weight-loss is fueling a global surge in counterfeit versions, according to Reuters interviews with law enforcement, anti-counterfeiting and public health officials. The U.S.-based Pharmaceutical Security Institute (PSI), an industry-backed organization that counts drugmakers Novo Nordisk and Eli Lilly as members, said it is working with agencies, including Europol, Interpol and U.S. Homeland Security, as well as companies that help identify counterfeit products such as Israel’s BrandShield.

By Bhanvi Satija and Patrick Wingrove (Reuters) - Johnson & Johnson on Tuesday said it has embarked on a two-year restructuring program for its ...

The FDA on Tuesday published letters warning two online vendors to stop selling unapproved versions of semaglutide and tirzepatide.